BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 39.40% | -278.99% | 73.20% | 28.49% | -65.15% |
| Total Depreciation and Amortization | 3.83% | 5.56% | 3.13% | -1.03% | 2.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -537.25% | 102.99% | -473.90% | -62.19% | 2,915.00% |
| Change in Net Operating Assets | 356.25% | -147.68% | 274.57% | -1,430.77% | -93.66% |
| Cash from Operations | 65.43% | -73.90% | 33.91% | -0.24% | -43.89% |
| Capital Expenditure | -19.89% | 2.39% | -42.97% | 5.73% | 13.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.89% | 2.39% | -42.97% | 5.73% | 13.62% |
| Total Debt Issued | -71.22% | 534.29% | -70.23% | -26.28% | 50.57% |
| Total Debt Repaid | 1.04% | -15.66% | 0.00% | 1.19% | 5.62% |
| Issuance of Common Stock | -100.00% | -- | -- | -99.86% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.08% | 669.37% | -72.34% | -41.83% | 89.01% |
| Foreign Exchange rate Adjustments | -110.00% | 145.45% | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.73% | 205.29% | -167.91% | -150.66% | 2,134.62% |
